Comparison

GIP (3-42), human - 1 mg

Item no. AS-61227
Manufacturer AnaSpec
Amount 1 mg
Category
Type Peptides
Format Lyophilized
Specific against other
Conjugate/Tag Unconjugated
Purity Peak Area by HPLC ≥95%
Sequence H-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH
Citations Gault, VA. et al. Endocrinol 175, 525 (2002), doi: 10.1677/joe.0.1750525
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias EGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ
Shipping Condition Room temperature
Available
Manufacturer - Type
Catalog
Manufacturer - Category
Peptides
Shipping Temperature
RT
Storage Conditions
- 20 °C
Molecular Weight
4749.6
Description
This peptide is from amino acid 3-42 of the full length 42-amino acid long GIP (Glucose-dependent Insulinotropic Polypeptide or also known as Gastric Inhibitory Polypeptide). The in-vivo degradation of the first two N-terminal amino acids (Tyr-Ala) by the enzyme dipeptidyl peptidase IV (DPP IV) results in making GIP (3-42) a potent antagonist as opposed to the agonist full length GIP on the GIP receptor.
Product Group
LB1A1Z
Research Area
Diabetes/Metabolism; Hormones; Cell Signaling / Lyophilized
Sequence One-Letter Code
EGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ
GTIN
5400535154530
Usage
Research use
UNSPSC
12352202

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close